ARMP Earnings

Quarterly EPS
$0.07
Q4 2024
$-0.18
Q1 2025
$-0.45
Q2 2025
$-0.74
Q3 2025
$-3.42
Q4 2025
$-3.16
Q1 2026
$2.02
Q2 2026
$1.15
Q3 2026
Latest Revenue3.2M
Latest Net Income54.9M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026$1.153.2M54.9M+173.6%+255.4%
Q2 2026$2.022.5M74.1M+15.7%+548.9%
Q1 2026-$3.16789.0K-115346000+60.7%-1,655.6%
Q4 2025-$3.421.1M-124298000-12.1%-4,985.7%
Q3 2025-$0.741.2M-26675000-61.0%-393.3%
Q2 2025-$0.452.2M-16295000—-280.0%
Q1 2025-$0.18491.0K-6531000-49.2%+73.9%
Q4 2024$0.071.2M2.6M-19.2%+112.7%
Q3 2024-$0.153.0M-5481000——
Q2 2024$0.2509.0M——
Q1 2024-$0.69966.0K-25021000——
Q4 2023-$0.551.5M-19847000——
Armata Pharmaceuticals (ARMP) — Earnings